| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |